Select for export Repurposing of recreational drugs: will these new ‘medicines’ (e.g., psychedelics, psilocybin, cannabinoids, LSD, MDMA, ketamine) deliver short- or longer-term benefits for those with depressive or other mood disorders? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1017/dep.2023.21 Copy citation Copy BibTeX Research Directions Depression 2023-10-12 Ian B. Hickie, Allan H. Young, F. Markus Leweke OpenAlex Published psilocybin DepressionPharmacologyTreatment-Resistant Depression Other More
Select for export Psychedelics and Psychotherapy: Is the Whole Greater than the Sum of its Parts? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/cpt.3050 PubMed 37795632 Copy citation Copy BibTeX Clinical Pharmacology & Therapeutics 2023-10-04 Robert H. Dworkin, Michael McDermott, Sandeep M. Nayak, Eric C. Strain OpenAlex Published psilocybin DepressionAnxietyAddiction Clinical Trial More
Select for export An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1) Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1186/s40814-023-01399-8 PubMed 37798662 Copy citation Copy BibTeX Pilot and Feasibility Studies 2023-10-04 C Donegan, Dimitri Daldegan-Bueno, Rachael L. Sumner, David B Menkes, William J. Evans, Nicholas Hoeh OpenAlex Published psilocybin DepressionPharmacologyReceptor Pharmacology Randomized Controlled Trial More
Select for export Psilocybin shows promising results in subjects continuing to use an antidepressant Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/pu.31089 Copy citation Copy BibTeX The Brown University Psychopharmacology Update 2023-10-03 Authors unavailable OpenAlex Published psilocybin DepressionAnxietyPharmacology Clinical Trial More
Select for export MODULATION OF SYNAPTIC FUNCTION AND NEURONAL NETWORK ACTIVITY BY SEROTONERGIC PSYCHEDELICS Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.ibneur.2023.08.608 Copy citation Copy BibTeX IBRO Neuroscience Reports 2023-09-30 Aneta Petrušková, Eva-Maria Weiss, Debarpan Guhathakurta, Enes Yağız Akdaş, Bartomeu Perelló, Renato Frischknecht OpenAlex Published psilocybin DepressionPTSDAddiction Other More
Select for export Neuroimaging in psychedelic drug development: past, present, and future. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41380-023-02271-0 PubMed 37759038 Copy citation Copy BibTeX Unknown journal 2023-09-26 Wall MB, Harding R, Zafar R, Rabiner EA, Nutt DJ, Erritzoe D. Europe PMC Published psilocybin DepressionPTSDAddiction Clinical Trial More
Select for export The psychedelic experience and treatment-resistant depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/wps.21140 PubMed 37713542 Copy citation Copy BibTeX World Psychiatry 2023-09-14 Guy M. Goodwin OpenAlex Published psilocybinpsilocin DepressionAnxietyNeuroplasticity Randomized Controlled Trial More
Select for export Tryptamines and Mental Health: Activating the 5-HT Receptor for Therapeutic Potential. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/acsmedchemlett.3c00390 PubMed 37849550 Copy citation Copy BibTeX Unknown journal 2023-09-14 Kargbo RB. Europe PMC Published psilocybin DepressionPTSDReceptor Pharmacology Clinical Trial More
Select for export Classic Psychedelics for the Treatment of Depressive Disorders: An Update for Psychiatrists in Training Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.ajp-rj.2023.190103 Copy citation Copy BibTeX American Journal of Psychiatry Residents Journal 2023-09-07 Lawrence Canale, Dhvanit Raval, Preet Chatha, Katie Penn, Claudia Weber, Catherine Stout OpenAlex Published psilocybin DepressionPharmacologyReceptor Pharmacology Clinical Trial More
Select for export Psilocybin-Assisted Cognitive Behavioral Therapy for Adults with Major Depressive Disorder: Rationale and Treatment Development Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1089/psymed.2023.0018 PubMed 40046861 Copy citation Copy BibTeX Psychedelic Medicine 2023-09-05 Marc J. Weintraub, Jessica Jeffrey, Charles S. Grob, Megan Ichinose, R. Lindsey Bergman, Ziva D. Cooper OpenAlex Published psilocybin DepressionChronic PainMechanism of Action Clinical Trial More
Select for export Single-Dose Psilocybin Treatment for Major Depressive Disorder Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1001/jama.2023.14530 PubMed 37651119 Copy citation Copy BibTeX JAMA 2023-08-30 Charles L. Raison, Gerard Sanacora, Joshua Woolley, Keith G. Heinzerling, Boadie W. Dunlop, Randall Brown OpenAlex Published psilocybin DepressionAnxietyAddiction Clinical Trial More
Select for export A Proposal to Study the Safety and Efficacy of Psilocybe cubensis in Preclinical and Clinical Studies as a Therapeutic Alternative for Major Depressive Disorder Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/02791072.2023.2246459 PubMed 37594163 Copy citation Copy BibTeX Journal of Psychoactive Drugs 2023-08-17 Raúl Escamilla, María Eva González-Trujano, Jesús M. González Mariscal, J. Martı́n Torres-Valencia, Héctor Guzmán-González, José Luis Vega OpenAlex Published psilocybin DepressionPharmacologyAnimal Study Animal Study More
Select for export Psilocybin-assisted psychotherapy for treatment-resistant depression: Which psychotherapy? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1111/inm.13214 PubMed 37589380 Copy citation Copy BibTeX International Journal of Mental Health Nursing 2023-08-16 Marie Crowe, Jenni Manuel, Dave Carlyle, Cameron Lacey OpenAlex Published psilocybin DepressionEmotional ProcessingRandomized Controlled Trial Randomized Controlled Trial More
Select for export use of psilocybin in the treatment of psychiatric disorders - review Abstract available at the source but not redistributed here. Read at source. Details DOI 10.12775/jehs.2023.43.01.009 Copy citation Copy BibTeX Journal of Education Health and Sport 2023-08-14 Justyna Woźniak, Rafał BOGACZ, Magdalena Gaik, Ewa URAM, Inga MAGDA, Karol Womperski OpenAlex Published psilocybin DepressionAddictionOCD Clinical Trial More
Select for export Australia Legalizes Psychedelics for Use in Depression, PTSD Therapy Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2023.09.9.20 Copy citation Copy BibTeX Psychiatric News 2023-08-14 Nick Zagorski OpenAlex Published psilocybin DepressionPTSDMechanism of Action Clinical Trial More
Select for export The Efficacy and Tolerability of Psilocybin in Participants With Treatment-Resistant Depression: a Phase 2, Randomized Feasibility Study Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2023-07-26 Brain and Cognition Discovery Foundation ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionClinical TrialTreatment-Resistant Depression Clinical Trial More
Select for export Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41386-023-01648-7 PubMed 37443386 Copy citation Copy BibTeX Neuropsychopharmacology 2023-07-12 Guy M. Goodwin, Megan Croal, David Feifel, John R. Kelly, Lindsey Marwood, Sunil Mistry OpenAlex Published psilocybin DepressionAnxietyReceptor Pharmacology Clinical Trial More
Select for export Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1192/bjo.2023.535 PubMed 37489299 Copy citation Copy BibTeX BJPsych Open 2023-06-30 Muhammad Ishrat Husain, Daniel M. Blumberger, David Castle, Nicole Ledwos, Elise Fellows, Brett D. M. Jones OpenAlex Published psilocybin DepressionAnxietyChronic Pain Randomized Controlled Trial More
Select for export Psychedelics, Meaningfulness, and the “Proper Scope” of Medicine: Continuing the Conversation Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1017/s0963180123000270 PubMed 37366110 Copy citation Copy BibTeX Cambridge Quarterly of Healthcare Ethics 2023-06-26 Katherine Cheung, Kyle Patch, Brian D. Earp, David B. Yaden OpenAlex Published psilocybin DepressionAddictionConsciousness Other More
Select for export Changes in synaptic markers after administration of ketamine or psychedelics: a systematic scoping review Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fpsyt.2023.1197890 PubMed 37435405 Copy citation Copy BibTeX Frontiers in Psychiatry 2023-06-25 Simon Zhornitsky, Henrique Nunes Pereira Oliva, Laura A. Jayne, AZA Stephen Allsop, Alfred P. Kaye, Marc N. Potenza OpenAlex Published psilocybinpsilocin DepressionAddictionNeuroplasticity Review Article More
